Best Practices in Chronic Myeloid Leukemia Monitoring and Management.


UNLABELLED : Optimal use of current therapeutic opportunities for chronic myeloid leukemia patients requires integration of clinical and laboratory monitoring. Assessment of molecular response (MR) by real-time quantitative polymerase chain reaction is the most sensitive way to monitor tyrosine kinase inhibitor (TKI) treatment efficacy. Besides major… (More)
DOI: 10.1634/theoncologist.2015-0337


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics